Compare

Faeth Therapeutics, Inc. vs CervoMed Inc. vs Gain Therapeutics, Inc. vs BriaCell Therapeutics Corp.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearFaeth Therapeutics, Inc.
FTH
CervoMed Inc.
CRVO
Gain Therapeutics, Inc.
GANX
BriaCell Therapeutics Corp.
BCTX
Year ended2025-12-312025-12-312025-12-312026-07-31
Revenuen/a$4.01Mn/an/a
Revenue growth (YoY)n/a-58.9%n/an/a
Gross marginn/an/an/an/a
Operating marginn/a-706.2%n/an/a
Net marginn/a-673.1%n/an/a
Net income-$21.09M-$26.97M-$20.16M-$34.90M
EPS (Diluted)-$16.72n/a-$0.61-$6.97
Operating cash flow-$20.45M-$23.45M-$18.47M-$28.65M
Free cash flow-$20.47Mn/an/a-$28.78M
Cash & equivalents$8.67M$8.24M$20.84M$9.85M
Total assets$22.90M$22.88M$22.82M$23.58M
Total liabilities$4.31M$4.66M$4.25Mn/a
Shareholders' equity$18.59M$18.22M$18.56M$15.56M
Return on year-end equity-113.4%-148.0%-108.6%-224.3%
Shares outstanding1.26M9.25M42.07M8.71M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearFaeth Therapeutics, Inc.CervoMed Inc.Gain Therapeutics, Inc.BriaCell Therapeutics Corp.
Latestn/a$4.01M
Ended 2025-12-31
$55.2K
Ended 2023-12-31
n/a
1 year earliern/a$9.74M
Ended 2024-12-31
$140.1K
Ended 2022-12-31
n/a
2 years earliern/a$7.14M
Ended 2023-12-31
$165.0K
Ended 2021-12-31
n/a
3 years earliern/a$0
Ended 2022-12-31
$28.9K
Ended 2020-12-31
n/a
4 years earliern/an/an/an/a